The estimated Net Worth of Craig A. Swandal is at least $141 Tausend dollars as of 21 March 2022. Mr. Swandal owns over 17,000 units of Apyx Medical stock worth over $21,420 and over the last 6 years he sold APYX stock worth over $0. In addition, he makes $119,868 as Independent Director at Apyx Medical.
Craig has made over 2 trades of the Apyx Medical stock since 2022, according to the Form 4 filled with the SEC. Most recently he exercised 17,000 units of APYX stock worth $84,660 on 21 March 2022.
The largest trade he's ever made was exercising 17,000 units of Apyx Medical stock on 21 March 2022 worth over $84,660. On average, Craig trades about 2,014 units every 6 days since 2018. As of 21 March 2022 he still owns at least 17,000 units of Apyx Medical stock.
You can see the complete history of Mr. Swandal stock trades at the bottom of the page.
Craig A. Swandal serves as Independent Director of the Company. Mr. Swandal has over 30 years of experience at public and privately-held medical technology and electronics manufacturing companies. He began his career in 1981 at Unisys Corporation, a manufacturer of main frame computer systems, where he held a variety of manufacturing positions of increasing responsibility. In 1995 he joined Silent Knight, a manufacturer of industrial fire and security systems, as a Manufacturing Manager and was promoted to Vice President of Operations. In 2001, Mr. Swandal joined Gyrus, a manufacturer of surgical devices, where he was responsible for the company’s manufacturing operations as Director of Operations and later Vice President of Operations. Following Gyrus’s acquisition of ACMI in 2005, Mr. Swandal was promoted to Senior Vice President and was responsible for the global operations of the combined company. He developed and executed Gyrus ACMI’s strategy to consolidate its manufacturing, distribution, customer service and service and repair operations and was a member of the leadership team that successfully sold the company to Olympus Corporation for $2.2 billion in 2008.
As the Independent Director of Apyx Medical, the total compensation of Craig Swandal at Apyx Medical is $119,868. There are 12 executives at Apyx Medical getting paid more, with Charles Goodwin having the highest compensation of $1,945,260.
Craig Swandal is 58, he's been the Independent Director of Apyx Medical since 2018. There are 6 older and 6 younger executives at Apyx Medical. The oldest executive at Apyx Medical Corporation is Andrew Makrides, 78, who is the Independent Chairman of the Board.
Craig's mailing address filed with the SEC is C/O APYX MEDICAL CORPORATION, 5115 ULMERTON ROAD, CLEARWATER, FL, 33760.
Over the last 6 years, insiders at Apyx Medical have traded over $0 worth of Apyx Medical stock and bought 97,836 units worth $253,260 . The most active insiders traders include Stavros G. Vizirgianakis, Charles D. Ii Goodwin und Moshe Citronowicz. On average, Apyx Medical executives and independent directors trade stock every 86 days with the average trade being worth of $18,719. The most recent stock trade was executed by Matthew C Hill on 13 August 2024, trading 5,336 units of APYX stock currently worth $6,030.
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and OEM. It offers electrosurgical generators based on its Helium Plasma Technology for cutting, coagulation, and ablation of soft tissue. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market that allows surgeons to operate with precision and eliminate unintended tissue trauma. It also develops, manufactures, and sells energy generators, disposable hand piece subassemblies, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Apyx Medical executives and other stock owners filed with the SEC include: